drugset / Trial / NCT00663767
A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Phase 2 study designed to test the ability of investigational study drug ARRY-371797 to reduce pain in a postoperative pain model (third molar extraction), and to further evaluate the drug's safety. Approximately 250 subjects from the US will be enrolled in this study.
Timeline
- Start
- 2008-04-07
- Primary completion
- 2008-06-20
- Completion
- 2008-06-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ARRY-371797 | Small molecule | — | Oral |
| Subject | Celecoxib | Other / unclassified | — | Oral |
Indications
No indication recorded.